This Article Full Text Full Text (PDF) All Versions of this Article: 54/1/11    most recent HYPERTENSIONAHA.108.120022v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Barton, M. Articles by Meyer, M. R. PubMed PubMed Citation Articles by Barton, M. Articles by Meyer, M. R. Related Collections Risk Factors Clinical Studies

(Hypertension. 2009;54:11.)
© 2009 American Heart Association, Inc.

Brief Reviews

Postmenopausal Hypertension

Mechanisms and Therapy

From the Departement für Innere Medizin, Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich, Zürich, Switzerland.

Correspondence to Matthias Barton, Departement für Innere Medizin, Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich, Rämistrasse 100, CH-8091 Zürich, Switzerland. E-mail barton@usz.ch

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Hypertension in women is often undiagnosed or inadequately treated, especially after menopause when cardiovascular risk increases. In premenopausal women, endogenous estrogens maintain vasodilation and thus contribute to blood pressure control. Aging and the loss of endogenous estrogen production after menopause are accompanied by increases in blood pressure, contributing to the high prevalence of hypertension in older women. Currently, 75% of postmenopausal women in the United States are hypertensive. The high prevalence of obesity, the lack of regular physical exercise, and dietary salt are important factors contributing to and aggravating postmenopausal hypertension. In view of the ongoing population aging throughout the world, diagnosis and treatment of hypertension in postmenopausal women are important to reduce the excess burden of associated cardiovascular disease and to improve outcomes of potentially fatal complications such as stroke and myocardial infarction. This article discusses current knowledge about the mechanisms and therapeutic issues related to postmenopausal hypertension.

	Hypertension: Important Determinant of Cardiovascular Risk in Women

 
More than 25% of the female adult world population is hypertensive.¹ Elevations in blood pressure in women are related to cardiovascular risk (Figure, panel A),^2,3 with the prevalence of hypertension being particularly high among women aged 60 years.¹ In the United States, 75% of postmenopausal women are hypertensive.⁴ Hypertension is often accompanied by other cardiovascular risk factors, eg, obesity, dyslipidemia, and diabetes mellitus.⁵ It is noteworthy that the prevalence of hypertension-related cardiovascular complications is greater in postmenopausal women than in age-matched men.⁶ Indeed, these complications represent the leading cause of death in women.⁶

View larger version (33K):   Figure. A, Cumulative incidence of cardiovascular . . . [Full Text of this Article]

This article has been cited by other articles:

				M. R. Meyer and M. Barton ER{alpha}, ER{beta}, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis Cardiovasc Res, September 1, 2009; 83(4): 605 - 610. [Full Text] [PDF]